Alzheimer’s Disease

5:11
Mild cognitive impairment: biomarker counseling, diagnosis and follow-up
Kristian Steen Frederiksen
5:16
Post-COVID-19 dementia landscape
Paola Barbarino
5:47
Is the world prepared for dementia?
Paola Barbarino
5:21
Diagnosing mild cognitive impairment
Kristian Steen Frederiksen
4:30
Alzheimer’s disease: what are the challenges when disease-modifying therapies become available?
Paola Barbarino
2:23
Metabolic deficits and neuropsychological changes in Alzheimer’s disease
Simon Bell
4:20
Dementia care during the COVID-19 pandemic
Paola Barbarino
1:32
Current diagnostic tools for Alzheimer’s disease
Simon Bell
2:41
NLGN1: potential biomarker of Alzheimer’s disease
Jonathan Brouillette
1:22
Neuroligin-1 is altered in Alzheimer’s disease
Jonathan Brouillette
4:00
Benefits of early detection in Alzheimer’s disease
Mary Paraskevaidi
2:59
Spectroscopic techniques for non-invasive diagnosis of Alzheimer’s disease
Mary Paraskevaidi
2:00
The role of blood spectroscopy in the Alzheimer’s disease diagnostic process
Mary Paraskevaidi
2:05
Alzheimer’s disease diagnosis: blood spectroscopy in the clinical setting
Mary Paraskevaidi
1:45
Alzheimer’s disease outlook: sensitive diagnostic approaches & efficient treatments
Mary Paraskevaidi
1:53
How does the gut influence the brain?
Cornelia van Duijn
The content of VJDementia is intended for healthcare professionals